{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:21:03Z","timestamp":1790889663367,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/100019418","name":"NIHR Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychiatr"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Recreational use of psychotogenic drugs has become more common in the last 30\u00a0years with consequent increase in drug-induced psychosis; 25\u201350% of such psychoses progress to schizophrenia within 5\u00a0years. Most cases result from abuse of methamphetamine or cannabis. The spread of methamphetamine psychosis has occurred without any liberalisation of laws; it is highly addictive and easy to make in small \u201ckitchen\u201d labs. The increase in cannabis use has been facilitated by a\u00a0softening of attitudes towards the drug, and in some countries, especially in North America, by legalisation for so-called \u201cmedicinal use\u201d and then recreational use. The potency of cannabis has greatly increased, especially in countries that have legalised its use, and the worldwide legal sales of cannabis for 2025 are estimated at $\u00a065\u00a0billion. The consequences are being seen with many reports of increases in the incidence of cannabis-psychosis and schizophrenia. In the 1980s some physicians predicted an epidemic of obesity and diabetes due to changes in diet and life style. Sadly, their predictions were correct. We are now at the beginning of a\u00a0similar epidemic of drug-induced psychosis. Public education campaigns of the type that decreased tobacco smoking are necessary to avoid psychiatric services being overwhelmed.<\/jats:p>","DOI":"10.1007\/s40211-025-00541-7","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T10:03:58Z","timestamp":1755684238000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The rising tide of drug-induced psychosis","Die wachsende Welle drogeninduzierter Psychosen"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-0519","authenticated-orcid":false,"given":"Robin M.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Paparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3218-6925","authenticated-orcid":false,"given":"Marta","family":"Di Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0666-7450","authenticated-orcid":false,"given":"Paul","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"7","key":"541_CR1","first-page":"661","volume":"162B","author":"RM Murray","year":"2013","unstructured":"Murray\u00a0RM, Paparelli\u00a0A, Morrison\u00a0PD, Marconi\u00a0A, Di Forti\u00a0M. What can we learn about schizophrenia from studying the human model, drug-induced psychosis? Neuropsychiatr Genet. 2013;162B(7):661\u201370.","journal-title":"Neuropsychiatr Genet"},{"issue":"12","key":"541_CR2","doi-asserted-by":"publisher","first-page":"694863","DOI":"10.3389\/fpsyt.2021.694863.eCollection20213","volume":"23","author":"A Fiorentini","year":"2021","unstructured":"Fiorentini\u00a0A, Cant\u00f9\u00a0F, Crisanti\u00a0C, Cereda\u00a0G, Oldani\u00a0L. Brambillo P. Substance-Induced Psychoses: An Updated Literature Review. Front Psychiatry. 2021;23(12):694863. https:\/\/doi.org\/10.3389\/fpsyt.2021.694863.eCollection20213.","journal-title":"Front Psychiatry"},{"key":"541_CR3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","volume":"26","author":"S Andreasson","year":"1987","unstructured":"Andreasson\u00a0S, Allebeck\u00a0P, Engstrom\u00a0A, Rydberg\u00a0U. Cannabis and Schizophrenia: A\u00a0longitudinal study of Swedish conscripts. Lancet. 1987;26:1483\u20136.","journal-title":"Lancet"},{"issue":"1","key":"541_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/15504263.2019.1674991","volume":"16","author":"Sideli L","year":"2020","unstructured":"Sideli L, Quigley H, La Cascia C\u00a0MRM. Cannabis use and the risk for psychosis and affective disorders. J\u00a0Dual Diagn. 2020;16(1):22\u201342.","journal-title":"J Dual Diagn"},{"issue":"15","key":"541_CR5","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1017\/S0033291724002058","volume":"54","author":"I Austin-Zimmerman","year":"2024","unstructured":"Austin-Zimmerman\u00a0I, Spinazzola\u00a0E, Quattrone\u00a0D, Wu-choi\u00a0B, Trotta\u00a0G, Li\u00a0Z. The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies. Psychol Med. 2024;54(15):4160\u201372. https:\/\/doi.org\/10.1017\/S0033291724002058.","journal-title":"Psychol Med"},{"issue":"3","key":"541_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","volume":"3","author":"T Schoeler","year":"2016","unstructured":"Schoeler\u00a0T, Monk\u00a0A, Sami\u00a0MB, Klamerus\u00a0E, Foglia\u00a0E, Brown\u00a0R, et\u00a0al. Continued versus discontinued cannabis use in patients with psychosis: A\u00a0systematic review and meta-analysis. Lancet Psychiatry. 2016;3(3):215\u201325.","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"541_CR7","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1017\/S0033291709005522","volume":"39","author":"PD Morrison","year":"2009","unstructured":"Morrison\u00a0PD, McKeown\u00a0Z, Lee\u00a0TD, Holt\u00a0DW, Powell\u00a0JF, Kapur\u00a0S, Murray\u00a0RM. The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009;39(10):1607\u201316. https:\/\/doi.org\/10.1080\/15504263.2019.1674991.","journal-title":"Psychol Med"},{"issue":"5","key":"541_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","volume":"6","author":"Di Forti M","year":"2019","unstructured":"Di Forti M, Quattrone D, TP\u00a0F, Jongsma\u00a0H, Kirkbride\u00a0J, Morgan\u00a0C, Murray\u00a0RM. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a\u00a0multicentre case-control study. Lancet Psychiatry. 2019;6(5):427\u201336. https:\/\/doi.org\/10.1016\/S2215-0366(19)30048-3.","journal-title":"Lancet Psychiatry"},{"issue":"15","key":"541_CR9","doi-asserted-by":"publisher","first-page":"7062","DOI":"10.1017\/S0033291723000399","volume":"53","author":"LJ Pow","year":"2023","unstructured":"Pow\u00a0LJ, Donald\u00a0C, Di Forti\u00a0M, Roberts Weiss Ayinde\u00a0THAO. Cannabis use and psychotic disorders in diverse settings in the Global South: findings from INTREPID II. Psychol Med. 2023;53(15):7062\u20139. https:\/\/doi.org\/10.1017\/S0033291723000399.","journal-title":"Psychol Med"},{"key":"541_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/S0033291703008353","volume":"33","author":"CK Chen","year":"2003","unstructured":"Chen\u00a0CK, Lin\u00a0SK, Sham\u00a0PC, Ball\u00a0D, Loh\u00a0EW, Hsiao\u00a0CC, Chiang\u00a0YL, Ree\u00a0SC, Lee\u00a0CH, Murray\u00a0RM. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003;33:1407\u201314.","journal-title":"Psychol Med"},{"issue":"4","key":"541_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/07067437221125302","volume":"68","author":"VS Tardelli","year":"2023","unstructured":"Tardelli\u00a0VS, Johnstone\u00a0S, Xu\u00a0B, Kim\u00a0S, Kim\u00a0H, Gratzer\u00a0D, George\u00a0TP, Le Foll\u00a0B, Castle\u00a0DJ. Marked Increase in Amphetamine-Related Emergency Department Visits and Inpatient Admissions in Toronto, Canada, 2014\u20132021. Can J Psychiatry. 2023;68(4):249\u201356.","journal-title":"Can J Psychiatry"},{"issue":"3","key":"541_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1741-7015-3-5","volume":"12","author":"M Odenwald","year":"2005","unstructured":"Odenwald\u00a0M, Neuner\u00a0F, Schauer\u00a0M, Elbert\u00a0T, Catani\u00a0C, Lingenfelder\u00a0B, Hinkel\u00a0H, H\u00e4fner\u00a0H, Rockstroh\u00a0B. Khat use as risk factor for psychotic disorders: a\u00a0cross-sectional and case-control study in Somalia. BMC Med. 2005;12(3):5. https:\/\/doi.org\/10.1186\/1741-7015-3-5.","journal-title":"BMC Med"},{"key":"541_CR13","doi-asserted-by":"publisher","first-page":"e061865","DOI":"10.1136\/bmjopen-2022-061865","volume":"12","author":"B Edwards","year":"2022","unstructured":"Edwards\u00a0B, Atkins\u00a0N. Exploring the association between khat use and psychiatric symptoms: a\u00a0systematic review. Bmj Open. 2022;12:e61865. https:\/\/doi.org\/10.1136\/bmjopen-2022-061865.","journal-title":"Bmj Open"},{"issue":"5","key":"541_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-024-06569-x","volume":"241","author":"RR Daswani","year":"2024","unstructured":"Daswani\u00a0RR, Choles\u00a0C, Kim\u00a0DD. Barr AM A systematic review and meta-analysis of synthetic cathinone use and psychosis. Psychopharmacology. 2024;241(5):1\u201322.","journal-title":"Psychopharmacology"},{"key":"541_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.schres.2018.02.049","volume":"199","author":"W-J Cheng","year":"2018","unstructured":"Cheng\u00a0W\u2011J, Chen\u00a0C\u2011H, Chen\u00a0C\u2011K, Huang\u00a0M\u2011C, Pietrzak\u00a0RH, Krystal\u00a0JH, Xu\u00a0K. Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia. Schis Res. 2018;199:313\u20138. https:\/\/doi.org\/10.1016\/j.schres.2018.02.049.","journal-title":"Schis Res"},{"key":"541_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","volume":"142","author":"JJH Rucker","year":"2018","unstructured":"Rucker\u00a0JJH, Iliff\u00a0J, Nutt\u00a0DJ. Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology. 2018;142:200\u201318. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.040.","journal-title":"Neuropharmacology"},{"key":"541_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1176\/appi.ajp.22010076","volume":"180","author":"EB Rognli","year":"2023","unstructured":"Rognli\u00a0EB, Heiberg\u00a0IH, Jacobsen\u00a0BK, et\u00a0al. Transition from substance-induced psychosis to schizophrenia spectrum disorder or bipolar disorder. Am J Psychiatry. 2023;180:437\u201344.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"541_CR18","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1017\/S0033291706008440","volume":"36","author":"Boydell J","year":"2006","unstructured":"Boydell J, van Os J, Caspi A, et\u00a0al. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychol Med. 2006;36(10):1441\u20136. https:\/\/doi.org\/10.1017\/S0033291706008440.","journal-title":"Psychol Med"},{"issue":"9","key":"541_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamapsychiatry.2021.1471","volume":"78","author":"C Hjorth\u00f8j","year":"2021","unstructured":"Hjorth\u00f8j\u00a0C, Posselt\u00a0CM, Nordentoft\u00a0M. Development over time of the population-attributable risk fraction for cannabis use disorder in schizophrenia in Denmark. Jama Psychiatry. 2021;78(9):1013\u20139.","journal-title":"Jama Psychiatry"},{"issue":"8","key":"541_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/jamapsychiatry.2020.0339","volume":"77","author":"RM Murray","year":"2020","unstructured":"Murray\u00a0RM, Hall\u00a0W. Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis? Jama Psychiatry. 2020;77(8):777\u20138. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.0339.","journal-title":"Jama Psychiatry"},{"key":"541_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1813","author":"Gon\u00e7alves-Pinho M","year":"2019","unstructured":"Gon\u00e7alves-Pinho M, Bragan\u00e7a M, Freitas A. Psychotic disorders hospitalizations associated with cannabis abuse or dependence: a\u00a0nationwide big data analysis. Int J Methods Psychiatr Res. 2019; https:\/\/doi.org\/10.1002\/mpr.1813. Published online December\u00a05.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"2","key":"541_CR22","doi-asserted-by":"publisher","first-page":"e2457868","DOI":"10.1001\/jamanetworkopen.2024.57868","volume":"8","author":"DT Myran","year":"2025","unstructured":"Myran\u00a0DT, Pugliese\u00a0M, Harrison\u00a0LD, Solmi\u00a0M, Anderson\u00a0KK, Fiedorowicz\u00a0JG, et\u00a0al. Changes in incident schizophrenia diagnoses associated with cannabis use disorder after cannabis legalization. Jama Netw Open. 2025;8(2):e2457868\u2013e2457868.","journal-title":"Jama Netw Open"},{"key":"541_CR23","doi-asserted-by":"crossref","unstructured":"Joshi S, Snyder KM, Thurstone C, Rivera BD, Feldman J, Cerd\u00e1 M, et\u00a0al. Changes in psychosis-related emergency department and hospitalization rates among youth following cannabis legalization in Colorado. Drug Alcohol Depend. 2025; 112719.","DOI":"10.1016\/j.drugalcdep.2025.112719"}],"container-title":["neuropsychiatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-025-00541-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40211-025-00541-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-025-00541-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:16:12Z","timestamp":1780463772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40211-025-00541-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1007\/s40211-025-00541-7","relation":{},"ISSN":["0948-6259","2194-1327"],"issn-type":[{"value":"0948-6259","type":"print"},{"value":"2194-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.M.\u00a0Murray, A.\u00a0Paparelli, M.\u00a0Di Forti and P.\u00a0Morrison declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}